PRESS RELEASE published on 06/30/2023 at 01:00, 2 years 5 months ago Gold Mountain Amends Annual General Meeting Date
PRESS RELEASE published on 06/26/2023 at 15:00, 2 years 5 months ago Gold Mountain Announces Management and Board Update
PRESS RELEASE published on 06/14/2023 at 23:00, 2 years 5 months ago Gold Mountain Reports its Q1 2024 Financial and Operating Results
PRESS RELEASE published on 05/25/2023 at 13:30, 2 years 6 months ago Silver Crown Royalties Exercises Top Up Option on Royalty Purchase
PRESS RELEASE published on 05/17/2023 at 15:00, 2 years 6 months ago Gold Mountain Completes its Final Property Payment
PRESS RELEASE published on 05/12/2023 at 14:00, 2 years 6 months ago Gold Mountain Enters into a Silver Royalty Agreement with Silver Crown Royalties Inc.
PRESS RELEASE published on 04/29/2023 at 00:20, 2 years 7 months ago Gold Mountain Reports Q4 and Full Year Ended January 31, 2023 Results
PRESS RELEASE published on 03/02/2023 at 15:15, 2 years 9 months ago Gold Mountain Provides Operational and Corporate Update
Published on 12/05/2025 at 02:35, 3 hours 43 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 18 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 13 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 18 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 47 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 27 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 52 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 3 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 7 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 18 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 33 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 33 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 17 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025